Previous studies have observed that SARS-CoV-2 RBD-IgG and IgA levels in adults begin to rise during the first days of infection, peak at 15-28 days post-symptom onset, and then remain detectable for at least 6 months post-infection (36–39). This evidence concerns the gene CD79A and infection.